Fig. 3From: Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expressionKaplan-Meier survival analysis according to HR statusComparison of post-recurrence breast cancer-specific survival among three HER2 groups in HR-positive (A), and HR-negative (B) patientsBack to article page